Related Experiment Video
Updated: Jun 25, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
[Hypogonadism, erectile dysfunction and endothelial dysfunction among HIV-infected men]
Oscar Moreno-Pérez1, Antonio Miguel Picó Alfonso, Joaquín Portilla
1Sección de Endocrinología y Nutrición, Hospital General Universitario de Alicante, Alicante, España.
Medicina Clinica
|March 7, 2009
Summary
HIV-associated hypogonadism is a common endocrine issue in men, leading to low testosterone. Early diagnosis and treatment are crucial for managing symptoms and improving quality of life.
Area of Science:
- Endocrinology
- Infectious Diseases
- Men's Health
Context:
- HIV-associated hypogonadism is a prevalent endocrine disorder with complex causes.
- Low testosterone levels impact muscle mass, exercise capacity, sexual function, cognition, mood, and overall quality of life in HIV-infected men.
- Hypogonadism contributes to metabolic changes, including insulin resistance, altered fat distribution, and endothelial dysfunction, increasing cardiovascular risk.
Purpose:
- To highlight the prevalence and multifactorial etiology of HIV-associated hypogonadism.
- To emphasize the broad clinical implications of low testosterone in HIV-infected men.
- To recommend diagnostic and therapeutic strategies for managing hypogonadism in this population.
Summary:
- HIV-associated hypogonadism presents non-specifically, rendering standard screening scales ineffective.
- Diagnosis requires periodic free testosterone (FTc) measurement in all HIV-infected men, especially at initial diagnosis.
- Hormone replacement therapy is indicated for men with FTc below reference levels after excluding reversible causes.
Impact:
- Low testosterone levels should be recognized as a cardiovascular risk factor in HIV-infected men.
- Managing hypogonadism can mitigate adverse metabolic effects, including insulin resistance and atherosclerosis.
- Addressing hypogonadism is essential for improving the comprehensive health and well-being of men living with HIV.
Related Concept Videos
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:23Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...